Stéphane Ramin‐Mangata

526 total citations
15 papers, 389 citations indexed

About

Stéphane Ramin‐Mangata is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Stéphane Ramin‐Mangata has authored 15 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Stéphane Ramin‐Mangata's work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Microbial Metabolism and Applications (2 papers). Stéphane Ramin‐Mangata is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Microbial Metabolism and Applications (2 papers). Stéphane Ramin‐Mangata collaborates with scholars based in France, Réunion and Australia. Stéphane Ramin‐Mangata's co-authors include Gilles Lambert, Brice Nativel, Valentin Blanchard, Kévin Chemello, Mikaël Croyal, Aurélie Thedrez, Michel Krempf, Bertrand Cariou, Stéphanie Billon‐Crossouard and Audrey Aguesse and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research and Nutrients.

In The Last Decade

Stéphane Ramin‐Mangata

15 papers receiving 385 citations

Peers

Countries citing papers authored by Stéphane Ramin‐Mangata

Since Specialization

Citations

This map shows the geographic impact of Stéphane Ramin‐Mangata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Ramin‐Mangata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Ramin‐Mangata more than expected).

Fields of papers citing papers by Stéphane Ramin‐Mangata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Ramin‐Mangata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Ramin‐Mangata. The network helps show where Stéphane Ramin‐Mangata may publish in the future.

Co-authorship network of co-authors of Stéphane Ramin‐Mangata

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Ramin‐Mangata. A scholar is included among the top collaborators of Stéphane Ramin‐Mangata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Ramin‐Mangata. Stéphane Ramin‐Mangata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function 2021 ·Atherosclerosis ·Stéphane Ramin‐Mangata, Aurélie Thedrez, Brice Nativel, Nicolas Diotel, Valentin Blanchard, Matthieu Wargny, Audrey Aguesse, Stéphanie Billon‐Crossouard, Cécile Vindis, Cédric Le May, Philippe Hulin, Mathieu Armanet, Valéry Gmyr, François Pattou, Mikaël Croyal, Olivier Meilhac, Estelle Nobécourt, Bertrand Cariou, Gilles Lambert	20
2	Genome-Wide Association of Proprotein Convertase Subtilisin/Kexin Type 9 Plasma Levels in the ELSA-Brasil Study 2021 ·Frontiers in Genetics ·Isabela M. Benseñor, (unknown), Isabella Ramos Lima, (unknown), Gilles Lambert, Stéphane Ramin‐Mangata, Márcio Sommer Bittencourt, Alessandra C. Goulart, Itamar S Santos, José Geraldo Mill, José Eduardo Krieger, Paulo A. Lotufo, Alexandre C. Pereira	2
3	Protective Effects of Medicinal Plant Decoctions on Macrophages in the Context of Atherosclerosis 2021 ·Nutrients ·(unknown), Stéphane Ramin‐Mangata, Nicolas Diotel, Wildriss Viranaïcken, (unknown), (unknown), (unknown), Olivier Meilhac	8
4	Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes 2019 ·Atherosclerosis ·Stéphane Ramin‐Mangata, Matthieu Wargny, Matthieu Pichelin, Cédric Le May, Aurélie Thedrez, Valentin Blanchard, Brice Nativel, Raúl D. Santos, Isabela M Benseñor, Paulo A. Lotufo, Gilles Lambert, Bertrand Cariou	17
5	CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA 2019 ·Immunology ·Brice Nativel, Stéphane Ramin‐Mangata, (unknown), (unknown), (unknown), Thomas Iwema, Nobunao Ikewaki, Philippe Gasque, Wildriss Viranaïcken	25
6	Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia 2019 ·JACC Basic to Translational Science ·Valentin Blanchard, Mikaël Croyal, (unknown), Stéphane Ramin‐Mangata, Kévin Chemello, Brice Nativel, Dirk Blom, A. David Marais, Gilles Lambert	6
7	PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate 2018 ·Clinical Science ·Mikaël Croyal, (unknown), (unknown), Jean-Christophe Le Bail, Elise F. Villard, Bruno Poirier, Audrey Aguesse, Stéphanie Billon‐Crossouard, Stéphane Ramin‐Mangata, Valentin Blanchard, Brice Nativel, Kévin Chemello, (unknown), Aurélie Thedrez, Philip Janiak, Michel Krempf, Christophe Boixel, Gilles Lambert, Etienne Guillot	35
8	PCSK9: from biology to clinical applications 2018 ·Pathology ·Valentin Blanchard, (unknown), Stéphane Ramin‐Mangata, Kévin Chemello, Brice Nativel, Gilles Lambert	37
9	Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study 2018 ·Journal of Lipid Research ·Valentin Blanchard, Stéphane Ramin‐Mangata, Stéphanie Billon‐Crossouard, Audrey Aguesse, (unknown), Kévin Chemello, Brice Nativel, Laurent Flet, Maud Chétiveaux, David Jacobi, Jean‐Marie Bard, Khadija Ouguerram, Gilles Lambert, Michel Krempf, Mikaël Croyal	28
10	Risk Factors of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae Occurrence in Farms in Reunion, Madagascar and Mayotte Islands, 2016–2017 2018 ·Veterinary Sciences ·(unknown), (unknown), (unknown), Guillaume Miltgen, (unknown), Stéphane Ramin‐Mangata, (unknown), Olivier Belmonte, Éric Cardinale	21
11	Key aspects of PCSK9 inhibition beyond LDL lowering 2018 ·Current Opinion in Lipidology ·Stéphane Ramin‐Mangata, Valentin Blanchard, Gilles Lambert	7
12	Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk 2017 ·Journal of clinical lipidology ·Benoît J. Arsenault, Francine Petrides, Fatiha Tabet, Weihang Bao, G. Kees Hovingh, S. Matthijs Boekholdt, Stéphane Ramin‐Mangata, Olivier Meilhac, David A. DeMicco, Kerry‐Anne Rye, David D. Waters, John J.P. Kastelein, Philip J. Barter, Gilles Lambert	46
13	Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor) 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Aurélie Thedrez, Dirk Blom, Stéphane Ramin‐Mangata, Valentin Blanchard, Mikaël Croyal, Kévin Chemello, Brice Nativel, Matthieu Pichelin, Bertrand Cariou, Steeve Bourane, Lihua Tang, Michel Farnier, Frederick J. Raal, Gilles Lambert	74
14	Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? 2017 ·Diabetes & Metabolism ·Mikaël Croyal, (unknown), (unknown), Stéphane Ramin‐Mangata, (unknown), F. Fall, Stéphanie Billon‐Crossouard, Audrey Aguesse, Tim Hollstein, David Sullivan, Estelle Nobécourt, Gilles Lambert, Michel Krempf	36
15	The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies 2017 ·Clinical Science ·Gilles Lambert, Aurélie Thedrez, Mikaël Croyal, Stéphane Ramin‐Mangata, C. David, Nicolas Diotel, (unknown), Michel Krempf, (unknown), Bruno Poirier, Jörg Blankenstein, Elise F. Villard, Etienne Guillot	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact